dc.contributor.author | Lavoie, Brian F. | eng |
dc.contributor.author | Sheldon, Ian M. | eng |
dc.coverage.spatial | United States | eng |
dc.date.issued | 2000 | eng |
dc.description.abstract | Comparative advantage based on resource endowments cannot explain United States (U.S.) leadership in biotechnology. Sources of heterogeneity within the process of research and development (R&D) investment, such as international differences in the maximum per-period rate of investment and regulatory uncertainty, offer a plausible explanation that can be incorporated into a real options approach to investment. | eng |
dc.description.bibref | Includes bibliographical references | eng |
dc.identifier.citation | AgBioForum 3(1) 2000: 47-52. | eng |
dc.identifier.issn | 1522-936X | eng |
dc.identifier.uri | http://hdl.handle.net/10355/1171 | |
dc.language | English | eng |
dc.publisher | AgBioForum | eng |
dc.relation.ispartofcollection | AgBioForum, vol. 3, no. 1 (2000) | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | |
dc.source.uri | http://www.agbioforum.missouri.edu/v3n1/v3n1a07-lavoie.htm | eng |
dc.subject | research and development (R&D) | eng |
dc.subject | comparative advantage | eng |
dc.subject.lcsh | Real options (Finance) | eng |
dc.subject.lcsh | Biotechnology -- Research | eng |
dc.title | The comparative advantage of real options : an explanation for the US specialization in biotechnology | eng |
dc.type | Article | eng |